Top

Published in:

01-01-2015 | Urogenital

Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma

Authors: F. Cornelis, E. Tricaud, A. S. Lasserre, F. Petitpierre, J. C. Bernhard, Y. Le Bras, M. Yacoub, M. Bouzgarrou, A. Ravaud, N. Grenier

Published in: European Radiology | Issue 1/2015

Abstract

Purpose

To retrospectively evaluate the ability of magnetic resonance (MR) imaging to differentiate low from high Fuhrman grade renal cell carcinoma (RCC).

Materials and methods

MR images from 80 consecutive pathologically proven RCC (57 clear cell, 16 papillary and 7 chromophobe) were evaluated. Double-echo chemical shift, dynamic contrast-enhanced T1- and T2-weighted images and apparent diffusion coefficient (ADC) maps were reviewed independently. Signal intensity index (SII), tumour-to-spleen SI ratio (TSR), ADC ratio, wash-in (WiI) and wash-out indices (WoI) between different phases were calculated and compared to pathological grade and size. The Fuhrman scoring system was used. Low grade (score ≤2) and high grade (score ≥3) tumours were compared using univariate and multivariate analyses.

Results

No associations between grade and imaging factors were found for papillary and chromophobe RCCs. For clear cell RCCs, there was a significant association between the grade and parenchymal WiI (WiI2) (P = 0.02) or ADCr (P = 0.03). A significant association between tumour grade and size (P = 0.01), WiI2 (P = 0.02) and ADCr (P = 0.05) remained in multivariate analysis.

Conclusions

Multiparametric MRI can be used to accurately differentiate low Fuhrman grade clear cell RCC from high grade. High Fuhrman grade (≥3) RCCs were larger, had lower parenchymal wash-in indices and lower ADC ratios than low grade.

Key Points

• Fuhrman grade of clear cell RCC can be differentiated with multiparametric MR imaging.

• Fuhrman grade significantly differed for size, parenchymal wash-in index and ADC ratio.

• No significant associations were found for papillary and chromophobe renal cell carcinoma.

Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30PubMedCrossRef

Kathrins M, Caesar S, Mucksavage P, Guzzo T (2013) Renal mass size: concordance between pathology and radiology. Curr Opin Urol 23:389–393PubMedCrossRef

Hsu JY, Wakelee HA (2009) Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. BioDrugs Clin Immunotherap Biopharm Gene Ther 23:289–304CrossRef

Karlo CA, Di Paolo PL, Chaim J et al (2014) Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 270:464–471PubMedCentralPubMedCrossRef

Cornelis F, Tricaud E, Lasserre AS et al (2014) Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours. Eur Radiol 24:1068–1080PubMedCrossRef

Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef

Breda A, Treat EG, Haft-Candell L et al (2010) Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. BJU Int 105:940–945PubMedCrossRef

Herts BR, Baker ME (1995) The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol 13:254–261PubMed

Heilbrun ME, Zagoria RJ, Garvin AJ et al (2007) CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR 188:1500–1505PubMedCrossRef

10.

Lechevallier E, Andre M, Barriol D et al (2000) Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216:506–510PubMedCrossRef

11.

Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MAS (2004) The natural history of incidentally detected small renal masses. Cancer 100:738–745PubMedCrossRef

12.

Ficarra V, Brunelli M, Novara G et al (2011) Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours. Pathology 43:149–155PubMedCrossRef

13.

Al Nazer M, Mourad WA (2000) Successful grading of renal-cell carcinoma in fine-needle aspirates. Diagn Cytopathol 22:223–226PubMedCrossRef

14.

Leveridge MJ, Finelli A, Kachura JR et al (2011) Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60:578–584PubMedCrossRef

15.

Vargas HA, Delaney HG, Delappe EM et al (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167PubMedCentralPubMedCrossRef

16.

Pedrosa I, Chou MT, Ngo L et al (2008) MR classification of renal masses with pathologic correlation. Eur Radiol 18:365–375PubMedCrossRef

17.

Cornelis F, Lasserre AS, Tourdias T et al (2013) Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central t2 signal intensity from renal cell carcinomas. AJR Am J Roentgenol 200:830–838PubMedCrossRef

18.

Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology 263:160–168PubMedCrossRef

19.

Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195:344–351CrossRef

20.

Kim JK, Kim SH, Jang YJ et al (2006) Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174–180PubMedCrossRef

21.

Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663PubMedCrossRef

22.

Busing KA, Kilian AK, Schaible T, Debus A, Weiss C, Neff KW (2008) Reliability and validity of MR image lung volume measurement in fetuses with congenital diaphragmatic hernia and in vitro lung models. Radiology 246:553–561PubMedCrossRef

23.

Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428PubMedCrossRef

24.

Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310:170PubMedCentralPubMedCrossRef

25.

True LD (2002) The time for accurate Fuhrman grading of renal cell carcinomas has arrived. Am J Clin Pathol 118:827–829PubMedCrossRef

26.

Kroeger N, Seligson DB, Klatte T et al (2012) Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol 61:888–895PubMedCrossRef

27.

Meskawi M, Sun M, Ismail S et al (2013) Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients. Mod Pathol 26:1144–1149PubMedCrossRef

28.

Goldstein NS (1997) The current state of renal cell carcinoma grading. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:977–980PubMedCrossRef

29.

Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624PubMedCrossRef

30.

Patard JJ, Leray E, Rioux-Leclercq N et al (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23:2763–2771PubMedCrossRef

31.

Somford DM, Hambrock T, Hulsbergen-van de Kaa CA et al (2012) Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series. Investig Radiol 47:153–158

32.

Oto A, Yang C, Kayhan A et al (2011) Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol 197:1382–1390PubMedCrossRef

33.

Goyal A, Sharma R, Bhalla AS et al (2012) Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol 53:349–358PubMedCrossRef

34.

Sandrasegaran K, Sundaram CP, Ramaswamy R et al (2010) Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 194:438–445PubMedCrossRef

35.

Lam JS, Shvarts O, Said JW et al (2005) Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 103:2517–2525PubMedCrossRef

36.

Klatte T, Said JW, de Martino M et al (2009) Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol 181:1558–1564PubMedCrossRef

37.

Minervini A, Di Cristofano C, Gacci M et al (2008) Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol 180:1284–1289PubMedCrossRef

38.

Delahunt B, McKenney JK, Lohse CM et al (2013) A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol 37:311–322PubMedCrossRef

39.

Thompson RH, Kurta JM, Kaag M et al (2009) Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 181:2033–2036PubMedCentralPubMedCrossRef

40.

Crispen PL, Wong Y-N, Greenberg RE, Chen DYT, Uzzo RG (2008) Predicting growth of solid renal masses under active surveillance. Urol Oncol 26:555–559PubMedCentralPubMedCrossRef

41.

Hsu RM, Chan DY, Siegelman SS (2004) Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 182:551–557PubMedCrossRef

42.

Delahunt B, Bethwaite PB, Nacey JN (2007) Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 39:459–465PubMedCrossRef

43.

Zhang C, Li X, Hao H, Yu W, He Z, Zhou L (2012) The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases. BJU Int 110:E481–E485PubMedCrossRef

44.

Maruyama M, Yoshizako T, Uchida K et al (2014) Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma. Acta Radiol

45.

Millet I, Doyon FC, Hoa D et al (2011) Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol 197:887–896PubMedCrossRef

Title: Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma
Authors: F. Cornelis
E. Tricaud
A. S. Lasserre
F. Petitpierre
J. C. Bernhard
Y. Le Bras
M. Yacoub
M. Bouzgarrou
A. Ravaud
N. Grenier
Publication date: 01-01-2015
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 1/2015
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-014-3380-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma

Abstract

Purpose

Materials and methods

Results

Conclusions

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 1/2015

Comparative evaluation of average glandular dose and breast cancer detection between single-view digital breast tomosynthesis (DBT) plus single-view digital mammography (DM) and two-view DM: correlation with breast thickness and density

Missed cancers in lung cancer screening – more than meets the eye

Robotic-assisted thermal ablation of liver tumours

Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging

Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging

Spiral computed tomographic pulmonary angiography in patients with acute pulmonary emboli and no pre-existing comorbidity: a prospective prognostic panel study